Also elected to serve on the board of the Montana BioScience Alliance are Jay Evans, president and chief executive officer of Inimmune and Tim Layton, Senior Manager of State government Affairs of Genentech.
Abel is president and chief executive officer of SiteOne Therapeutics, an early-stage biotechnology company developing non-opioid therapeutics for acute and chronic pain.
His background includes successfully leading complex development-stage life science companies, identifying and in-licensing promising new drug candidates, raising more than USD 100m in capital to fund operations, and establishing strategic partnerships and transactions with leading pharmaceutical and biotech companies.
Abel served as chief executive officer of Corthera, Inc., from October 2007 through the successful sale of the company to Novartis in February 2010.
Prior to joining Corthera, Abel was a founder and chief financial officer of Cerexa, Inc. from its inception in July 2005 through the successful sale of the company to Forest Laboratories in January 2007.
Before Cerexa‚ he was the chief financial officer of Peninsula Pharmaceuticals, Inc. from January 2003 through the sale of the company to Johnson and Johnson in June 2005.
Earlier in his career‚ Abel spent four years at Eli Lilly and Co within the finance and strategy organizations. He also held a variety of financial leadership positions during his nine years at DowBrands‚ Inc., a wholly-owned subsidiary of The Dow Chemical Co.
The Montana Bioscience Alliance serves as a hub for Montana's biotechnology companies, entrepreneurs, laboratories, hospitals, clinics and universities.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer